IL-33-PU.1 Transcriptome Reprogramming Drives Functional State Transition and Clearance Activity of Microglia in Alzheimer’s Disease
Authors:
- Shun-Fat LauSLShun-Fat Lau
- Amy K.Y. FuAFAmy K.Y. Fu
- Nancy Y. IpNINancy Y. Ip
Open Access
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 31 (3) , 107530
Abstract
No abstract availableKeywords
Funding Information
- Innovation and Technology Commission
- Research Grants Council, University Grants Committee
- University Grants Committee
This publication has 87 references indexed in Scilit:
- Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegenerationSeminars in Immunopathology, 2013
- Factors regulating microglia activationFrontiers in Cellular Neuroscience, 2013
- F-box protein FBXL19–mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammationNature Immunology, 2012
- Lipoprotein Lipase Is a Novel Amyloid β (Aβ)-binding Protein That Promotes Glycosaminoglycan-dependent Cellular Uptake of Aβ in AstrocytesJournal of Biological Chemistry, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- The Role of Apolipoprotein E in Alzheimer's DiseaseNeuron, 2009
- Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseMolecular Psychiatry, 2009
- Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s diseaseNature, 2008
- IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factorin vivoProceedings of the National Academy of Sciences, 2007